Fundraising FoxMarinus Pharmaceuticals
Radnor, US · Delaware corporation · 8 known investors
Find your way into Marinus Pharmaceuticals
Sign up to see every warm intro you have to Marinus Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Marinus Pharmaceuticals team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Board
Investors · 8
How we know: Avoro Capital Advisors's portfolio page · Not right? Tell us
How we know: Bain Capital Life Sciences's portfolio page · Not right? Tell us
How we know: Canaan Partners's portfolio page · funding news · biospace.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Connecticut Innovations's portfolio page · Not right? Tell us
How we know: Sofinnova Ventures's portfolio page · funding news · biospace.com · the VCSheet dataset · Not right? Tell us
How we know: a partner's Signal profile · funding news · biospace.com · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · biospace.com · Not right? Tell us
Funding
SEC filings, press & company announcements$31.2M disclosed across 2 of 3 rounds · 2005–2022
- Undisclosed amountSeries AOct 2005
Canaan Partners (lead), Domain Associates (lead), Sofinnova Ventures (lead), Foundation Medical Partners
Source ↗
▶$1.2MraisedApr 2022 · 1 investors · PharmaceuticalsRule 506(b)
- Tim M. MaylebenDirector
- Nicole VitulloDirector
- Michael R. DoughertyDirector
- Charles AustinDirector
- Steven E. PfanstielExecutive Officer
- Saraswathy Nochur, Ph.D.Director
- Elan EzicksonDirector
- Martha Manning, Esq.Executive Officer
- Joseph Hulihan, M.D.Executive Officer
- Scott Braunstein, M.D.Executive Officer, Director
- Santiago Arroyo, M.D., Ph.D.Director
- Seth H.Z. FischerDirector
- Offering amount
- $1.2M
- Amount sold
- $1.2M
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$30MraisedDec 2019 · 4 investors · PharmaceuticalsRule 506(b)
- Scott Braunstein, MDExecutive Officer, Director
- Enrique J. Carrazana, MDDirector
- Michael R. DoughertyDirector
- Seth H.Z. FischerDirector
- Tim M. MaylebenDirector
- Nicole VitulloDirector
- Elan EzicksonDirector
- Edward F. SmithExecutive Officer
- Joe Hulihan, MDExecutive Officer
- Offering amount
- $30M
- Amount sold
- $30M
- Minimum investment
- $4.6M
- Sales commissions
- $1.8M
- Placement agents
- Oppenheimer & Co., Inc, Ladenburg Thalmann & Co. Inc., Craig-Hallum Capital Group LLC
- First sale
- Dec 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Companies working in the same space as Marinus Pharmaceuticals.
In the news
Frequently asked questions
- Who are Marinus Pharmaceuticals's investors?
- Marinus Pharmaceuticals's investors include Avoro Capital Advisors, Bain Capital Life Sciences, Canaan Partners, Connecticut Innovations, Sofinnova Ventures, Domain Associates, Flare Capital Partners, FOUNDATION MEDICAL PARTNERS.
- How much funding has Marinus Pharmaceuticals raised?
- Marinus Pharmaceuticals has disclosed $31.2M raised across 2 of its 3 known rounds.
- Where is Marinus Pharmaceuticals headquartered?
- Marinus Pharmaceuticals is headquartered in Radnor, US.